Centre Léon-Bérard (UNICANCER)


Research / Science organisation

Location:
Lyon, France


Publications in cooperation with FAU scientists


Machiela, M.J., Gruenewald, T.G.P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E.,... Delattre, O. (2018). Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. In CANCER RESEARCH. Atlanta, GA, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Machiela, M.J., Grunewald, T.G.P., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E.,... Delattre, O. (2018). Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nature Communications, 9(1). https://dx.doi.org/10.1038/s41467-018-05537-2
Machiela, M.J., Gruenewald, T.G., Surdez, D., Reynaud, S., Mirabeau, O., Karlins, E.,... Delattre, O. (2018). Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Levi, J.M.H., Van Limbergen, E., Gal, J., Schiappa, R., Polgar, C., Kauer-Dorner, D.,... Strnad, V. (2018). Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis. (pp. S80-S80).
Higgins, M., Curigliano, G., Dieras, V., Kuemmel, S., Kunz, G., Fasching, P.,... Goss, P. (2017). Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study. Breast Cancer Research and Treatment, 162(3), 479-488. https://dx.doi.org/10.1007/s10549-017-4130-y
Easton, D.F., Lesueur, F., Decker, B., Michailidou, K., Li, J., Allen, J.,... Chenevix-Trench, G. (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics, 53(5), 298-309. https://dx.doi.org/10.1136/jmedgenet-2015-103529
Kager, L., Whelan, J., Dirksen, U., Hassan, B., Anninga, J., Bennister, L.,... Bielack, S.S. (2016). The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. Clinical Sarcoma Research, 6. https://dx.doi.org/10.1186/s13569-016-0043-5
Apetoh, L., Smyth, M.J., Drake, C.G., Abastado, J.-P., Apte, R.N., Ayyoub, M.,... Anderson, A.C. (2015). Consensus nomenclature for CD8(+) T cell phenotypes in cancer. OncoImmunology, 4(4), e998538. https://dx.doi.org/10.1080/2162402X.2014.998538
Leyvraz, S., Piperno-Neumann, S., Suciu, S., Baurain, J.F., Zdzienicki, M., Testori, A.,... Keilholz, U. (2014). Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial. Annals of Oncology, 25(3), 742-6. https://dx.doi.org/10.1093/annonc/mdt585
Puisieux, A., Brabletz, T., & Caramel, J. (2014). Oncogenic roles of EMT-inducing transcription factors. Nature Cell Biology, 16(6), 488-94. https://dx.doi.org/10.1038/ncb2976

Last updated on 2016-21-06 at 13:05